
Opinion|Videos|July 12, 2024
Limitations on Optimal Biomarker Testing Rates
A panel of experts discuss the current limitations of optimal biomarker testing rates in the community.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What may currently limit optimal biomarker testing rates in the community?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Accept Deidentified Real-World Evidence for Select Medical Device Applications
2
ACA Subsidy Expiration Raises Concerns for Behavioral Health Access and ED Strain
3
HIV in 2025 Defined by Challenges Throughout the Year, Despite Some Advances
4
FDA Approves Intranasal Etripamil for Type of Arrhythmia
5







































